“A Randomized study of sofosbuvir plus ribavirin with and without PEG interferon alpha 2b in treatment of hepatitis C genotype 3 infection: Real life data from a Tertiary Care Center” (2018) International Journal of Biomedical and Advance Research, 9(3), pp. 91–95. doi:10.7439/ijbar.v9i3.4673.